Autor: |
Heney, Niall M., Koontz, Warren W., Barton, Bruce, Soloway, Mark, Trump, Donald L., Hazra, Tapan, Weinstein, Ronald S. |
Zdroj: |
The Journal of Urology; December 1988, Vol. 140 Issue: 6 p1390-1393, 4p |
Abstrakt: |
A prospective randomized clinical trial was conducted by the National Bladder Cancer Group to compare thiotepa and mitomycin C in ablating residual Ta, T1 and TIS transitional cell carcinoma of the bladder. Eight weekly instillations were given followed by cystoscopy 4 weeks after the treatment was stopped. The over-all complete response rate based on cystoscopy and either biopsy or cytology was 26 per cent for thiotepa versus 39 per cent for mitomycin C (p equals 0.08). The greatest efficacy was seen in the Ta group with mitomycin C demonstrating superiority over thiotepa. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|